Xlife Sciences AG (SWX:XLS)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
16.85
-0.15 (-0.88%)
At close: Jul 31, 2026
Market Cap96.08M -28.5%
Revenue (ttm)275.31K -67.0%
Net Income-21.55M
EPS-3.76
Shares Out 5.70M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,363
Open16.25
Previous Close17.00
Day's Range16.25 - 17.00
52-Week Range15.75 - 26.80
Beta0.45
Analystsn/a
Price Targetn/a
Earnings DateSep 24, 2026

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medical technology to develop innov... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 20
Stock Exchange SIX Swiss Exchange
Ticker Symbol XLS
Full Company Profile

Financial Performance

Financial Statements